Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

@article{Bouza2004EfficacyAS,
  title={Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.},
  author={Carmen Bouza and Ma de los Angeles and Ana Mu{\~n}oz and Jos{\'e} Mar{\'i}a Amate},
  journal={Addiction},
  year={2004},
  volume={99 7},
  pages={
          811-28
        }
}
AIMS To ascertain the efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence. METHODS Systematic review of the literature (1990-2002) and meta-analysis of full published randomized and controlled clinical trials assessing acamprosate or naltrexone therapy in alcohol dependence. Estimates of effect were calculated according to the fixed-effects model. MEASUREMENTS Relapse and abstinence rates, cumulative abstinence duration and treatment compliance were… 

Figures and Tables from this paper

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.
TLDR
To ensure that the real-world treatment is as effective as the research findings, a form of psychosocial therapy should be concomitantly given to all alcohol-dependent patients receiving naltrexone administration.
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
TLDR
The results of this study support the efficacy of naltrexone in the relapse prevention of alcoholism amongst those with low levels of clinical depression and alcohol dependence severity.
Comparing topiramate with naltrexone in the treatment of alcohol dependence.
TLDR
The results of this study support the efficacy of topiramate in the relapse prevention of alcoholism.
Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
TLDR
The efficacy of once per month, injectable extended-release naltrexone (XR-NTX 380 mg) in relatively higher severity alcohol dependence for both reduction in heavy drinking and maintenance of abstinence is supported, with implications for the role of adherence pharmacotherapy.
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
TLDR
A meta-analysis examined when naltrexone and acamprosate are most helpful by testing the relative efficacy of each medication given its presumed mechanism of action and whether different ways of implementing each medication moderate its effects.
Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
TLDR
The role of naltrexone in reducing craving when that craving is highly salient is supported, and baseline levels of depression were the best predictor of daily craving.
Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
TLDR
Re-analysis of the rate of complete abstinence, percent days abstinent, and the time to first drink confirmed the original findings for the efficacy of acamprosate in the treatment of alcohol dependence.
Acamprosate for alcohol dependence.
TLDR
Acamprosate appears to be an effective and safe treatment strategy for supporting continuous abstinence after detoxification in alcohol dependent patients and should be valued against the background of the relapsing nature of alcoholism and the limited therapeutic options currently available for its treatment.
Efficacy of Extended-Release Naltrexone in Alcohol-Dependent Patients Who Are Abstinent Before Treatment
TLDR
XR-NTX 380 mg prolonged abstinence and reduced the number of heavy drinking days and drinking days in patients who were abstinent for as few as 4 days before treatment initiation, demonstrating a dose-response effect.
Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes
TLDR
When the efficacy profiles of the two drugs were compared, acamprosate was found to be more effective in preventing a lapse, whereas naltrexone was better in prevented a lapse from becoming a relapse.
...
...

References

SHOWING 1-10 OF 85 REFERENCES
Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study.
TLDR
It was concluded that acamprosate was a useful and safe pharmacotherapy in the long-term treatment of alcoholism and concomitant administration of disulfiram improved the effectiveness of acamposate.
Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
TLDR
Both naltrexone and acamprosate are efficacious in reducing alcohol consumption in alcoholics, however, their specific role in alcoholism treatment remains to be more clearly defined.
NALTREXONE VERSUS ACAMPROSATE: ONE YEAR FOLLOW-UP OF ALCOHOL DEPENDENCE TREATMENT
TLDR
There were non-significant trends for the naltrexone group to comply better with medication, to stay in the study longer, and to show greater improvement over baseline in serum GGT, though this could not explain their better outcome.
Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.
TLDR
Acamprosate proved to be a safe and effective aid in treating alcohol-dependent patients and in maintaining the abstinence of patients during 2 years.
Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials.
TLDR
The meta-analysis of benefit indicates that naltrexone is superior to placebo, and there is no significant difference between nALTrexone and placebo in terms of the number of subjects with at least one adverse event or the numberof subjects who discontinued the trial due to an adverse event.
Naltrexone in the treatment of alcohol dependence.
Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
TLDR
Acamprosate treatment over 180 days was consistently more effective than placebo to maintain abstinence and to diminish relapse severity and no differential effect was noted for anxiety, depression or craving.
Improving Naltrexone Response
TLDR
Support is provided for the use of an intervention that targets medication compliance when prescribing nal-trexone, a FDA-approved medication for alcohol dependence, if it is supported and help patients to consistently take their medication.
Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
TLDR
Motivated individuals with moderate alcohol dependence can be treated with greater effectiveness when naltrexone is used in conjunction with weekly outpatient cognitive behavioral therapy.
Relapse Prevention in Alcoholics
TLDR
Both drugs were effective, but acamprosate may be preferred above naltrexone because of its proven long-term effectiveness with carry-over after stopping the medication for at least 1 year.
...
...